tenofovir has been researched along with Amphetamine-Related Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azariah, S; Coughlan, E; Giola, M; Ludlam, A; Myers, J; O'Toole, C; Pohl, M; Rich, J; Saxton, P | 1 |
| Ackers, M; Buchbinder, SP; Chillag, K; Colfax, G; Collins, B; Grohskopf, L; Gvetadze, R; Liu, AY; Mayer, K; Oʼhara, B; Pathak, S; Paxton, L; Thompson, M; Vittinghoff, E | 1 |
1 trial(s) available for tenofovir and Amphetamine-Related Disorders
| Article | Year |
|---|---|
Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United States.
Topics: Adenine; Adolescent; Adult; Amphetamine-Related Disorders; Anti-HIV Agents; Boston; Double-Blind Method; Follow-Up Studies; Georgia; Health Knowledge, Attitudes, Practice; HIV Infections; HIV Seronegativity; Homosexuality, Male; Humans; Male; Middle Aged; Organophosphonates; Risk Assessment; Risk-Taking; San Francisco; Sexual Partners; Tenofovir; Treatment Outcome; Unsafe Sex | 2013 |
1 other study(ies) available for tenofovir and Amphetamine-Related Disorders
| Article | Year |
|---|---|
Implementing HIV pre-exposure prophylaxis (PrEP): let's not get caught with our pants down.
Topics: Amphetamine-Related Disorders; Anti-HIV Agents; Cost-Benefit Analysis; Drug Combinations; Emtricitabine; Female; Healthcare Disparities; HIV Infections; Humans; Male; Morals; Patient Selection; Pre-Exposure Prophylaxis; Risk Factors; Sexual and Gender Minorities; Sexual Partners; Tenofovir; Transgender Persons; Treatment Outcome; Unsafe Sex; Vulnerable Populations | 2018 |